Mark E Layton

3PUBLICATIONS
13CO-AUTHORS
Biologically active moleculesProteins and peptidesMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral NaV1.8 Inhibitor for the Treatment of Pain.

|Feb 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic.

Valerie W Shurtleff, Mark E Layton, Craig A Parish

|Jan 10, 2023
Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia.

Mark E Layton, Jeffrey C Kern, Timothy J Hartingh

Pageof 1

Frequent Collaborators

2 joint publications

James J Perkins

1 joint publications

William D Shipe

1 joint publications

Izzat Raheem

1 joint publications

Georgia B McGaughey